The invention discloses a
genetic engineering vaccine of lymphocystis
disease of
flounder paralichthys olivaceus and a production method thereof, which is characterized in that the method for producing the
genetic engineering vaccine comprises the following steps: inserting
gene MCP segments (size: 0.6 KB) of
nucleocapsid proteins of lymphocystis
disease virus (LCDV) into an eukaryotic
expression vector pEGFP-N2 so as to form recombinant plasmids pEGFP-N2-LCDV-MCP (size: 0.6 KB); translating the recombinant plasmids into
escherichia coli so as to prepare production strains, lining the production strains to a Mi nca
agar plate so as to separate and purify the production strains and then prepare and determine qualified level-1 strains; then inoculating the level-1 strains in an
agar flat
bottle, after cultivating the level-1 strains for 24h-48h at a temperature of 37 DEG C, identifying the obtained level-1 strains and determining qualified level-2 strains; carrying out
fermentation and cultivation on the obtained level-2 strains so as to obtain fermentative level-2 strain culture solution; carrying out
bacteria collection and
centrifugation as well as
plasmid DNA extraction and purification on the fermentative level-2 strain culture bacterium solution, then carrying out collection,
centrifugation,
plasmid DNA extraction, purification and routine inspection on the cultured bacterium solution, if qualified, the
genetic engineering vaccine is obtained. The genetic
engineering vaccine of the invention has the advantages of complete and simple production process, good stability and low cost; and compared with current inactivated vaccines, attenuated vaccines, polypeptide vaccines,
subunit vaccines and recombinant polypeptide vaccines and the like, the genetic
engineering vaccine of the invention has good immunization effect and no
adverse effect.